Filter
331
Text search:
antibiotic
stewardship
Featured
Recommendations
33
New Publications
65
Language
Document type
Studies & Reports
124
Guidelines
84
No document type
43
Strategic & Response Plan
30
Manuals
14
Fact sheets
12
Online Courses
8
Training Material
5
Situation Updates
5
Resource Platforms
4
Dashboards/Maps
1
Infographics
1
Countries / Regions
South Africa
17
India
14
Kenya
13
Africa
10
Global
10
Latin America and the Carribbean
7
Nigeria
6
Ethiopia
6
Malawi
6
Namibia
5
Sierra Leone
4
Ghana
4
Nepal
4
Tanzania
4
Bangladesh
4
Uganda
3
Burkina Faso
2
Zimbabwe
2
Philippines
2
Pakistan
2
Zambia
2
Thailand
2
Mozambique
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Western and Central Europe
2
Laos
2
Tajikistan
2
Senegal
1
Mali
1
Guinea-Bissau
1
USA
1
Saudi Arabia
1
Cameroon
1
Somalia
1
Iraq
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Cambodia
1
Indonesia
1
Sudan
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Ukraine
1
Libya
1
Angola
1
Lesotho
1
Myanmar / Burma
1
Sri Lanka
1
West and Central Africa
1
South–East Asia Region
1
Asia
1
Fiji
1
Bhutan
1
Eastern Europe
1
Armenia
1
Southern Africa
1
Russia
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Gabon
1
Maldives
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
87
Clinical Guidelines
10
Key Resources
9
Women & Child Health
7
Public Health
4
Pharmacy & Technologies
3
Capacity Building
2
Toolboxes
AMR
238
Pharmacy
15
Planetary Health
13
TB
11
Global Health Education
6
Rapid Response
5
Caregiver
5
2.0 Rapid Response
4
Cholera
3
HIV
3
COVID-19
3
NTDs
2
Ebola & Marburg
1
Polio
1
Conflict
1
Health Financing Toolbox
1
NCDs
1
The State of the World's Midwifery
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill
...
To understand the national situation, Ethiopia did a situation assessment, launched its first strategy in 2011, and took action to contain AMR, as detailed in the blue boxes found throughout this strategy. This updated version of the strategy was in response to the revised health and medicines polic
...
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release into the environment. The purpose of the document is to identify existing instruments and standards in
...
The National Action Plan (NAP) has been developed based on the model recommended in the global Action Plan. Local data on on-going interventions were collected from technical informants in the various areas of work. These were analysed using the policy framework provided by the AMR policy document.
...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has
...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating
...
Antimicrobial resistance has become one of the most eminent threats to global health and a rising concern for healthcare specialists. All around the world, many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in high morbidity and mortality with
...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy
...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant
...
Ending Cholera. A global roadmap to 2030
recommended
Ending Cholera—A Global Roadmap to 2030 operationalises the new global strategy for cholera control at the country level and provides a concrete path toward a world in which cholera is no longer a threat to public health
Manual for Early Implementation
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2
...
The global increase of healthcare-associated infections (HAI) presents a growing concern in healthcare worldwide. According to the European Centre for Disease Prevention and Control (ECDC), the annual number of HAI exceeds 2.6million and produces the highest estimated amou
...
Health care-associated infections (HAIs) affect patients and health systems every day, causing immense suffering, driving higher health-care costs and hampering efforts to achieve high-quality care for all. HAIs are often difficult to treat, are the major driver of antimicrobial resistance (AMR) and
...
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
La publication fournit une vue d'ensemble et une analyse des instruments internationaux qui établissent des normes relatives à l'utilisation des antimicrobiens dans les secteurs humain, animal et végétal, et à leur rejet dans l'environnement. L'objectif de ce document est d'identifier les instr
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
